David Loomis
Comptroller/Controller/Auditor at ARVINAS, INC.
Net worth: 350 880 $ as of 2024-03-30
Profile
David Loomis is currently the Chief Accounting Officer & VP-Corporate Controller at Arvinas, Inc. Prior to his current position, he worked as a Controller at Biohaven Pharmaceutical Holding Co. Ltd.
and Biohaven Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC.
0.01% | 2024-02-22 | 8,500 ( 0.01% ) | 350 880 $ | 2024-03-30 |
David Loomis active positions
| Companies | Position | Start |
|---|---|---|
| ARVINAS, INC. | Comptroller/Controller/Auditor | 2022-11-06 |
Former positions of David Loomis
| Companies | Position | End |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 2022-10-31 |
| BIOHAVEN LTD. | Comptroller/Controller/Auditor | 2022-10-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- David Loomis